Quikhale SF 250 HFA based Inhaler

Quikhale SF 250 HFA based Inhaler is a prescription combination inhaler that contains salmeterol and fluticasone propionate in the 250-strength labeled form. It belongs to the long-acting beta2-agonist (LABA) plus inhaled corticosteroid class and is used for ongoing control of asthma symptoms, not for quick relief of an attack. This Quikhale SF 250 HFA based Inhaler helps reduce airway inflammation and keep the airways open so breathing is easier over time. It is supplied as an HFA-based inhaler for inhalation into the lungs.

How it works: Salmeterol relaxes the muscles around the airways so they stay open longer, while fluticasone propionate reduces swelling and irritation inside the lungs. Used through the Quikhale SF 250 HFA based Inhaler, these medicines work directly in the airways to help prevent asthma symptoms when taken regularly.

Quikhale SF 250 HFA based Inhaler is a higher-strength maintenance inhaler, so it is typically chosen when a doctor wants more anti-inflammatory support than lower-strength options would provide. Because it contains the 250-labeled dose in each inhaler actuation, it is not the usual starting choice for someone newly diagnosed or for sudden symptoms, and it should be used only in patients a clinician has already assessed.

• Maintenance treatment of asthma
• Prevention of wheezing
• Reduction of shortness of breath from asthma
• Decreasing nighttime asthma symptoms
• Long-term control of airway inflammation

• Use Quikhale SF 250 HFA based Inhaler exactly as prescribed; it is inhaled, not swallowed.
• Shake the inhaler well before each use and follow the inhaler instructions for priming if it is new or has not been used recently.
• Breathe out fully, place the mouthpiece in your mouth, and inhale slowly and deeply while pressing the canister.
• Hold your breath for about 10 seconds if you can, then exhale slowly.
• Rinse your mouth with water and spit it out after each use to help lower the risk of oral thrush.
• Do not use this inhaler for sudden asthma attacks; keep your rescue inhaler available for quick relief.

Each use of Quikhale SF 250 HFA based Inhaler delivers the labeled 250-strength combination dose of salmeterol and fluticasone propionate by inhalation. The exact schedule depends on the prescriber, but this type of maintenance inhaler is commonly used on a regular twice-daily schedule, and the maximum number of inhalations per day should never exceed the doctor’s instructions.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Salmeterol + Fluticasone Propionate may include:

• Throat irritation
• Hoarseness or voice changes
• Cough after inhalation
• Headache
• Oral thrush in the mouth
• Tremor or shakiness
• Mild palpitations or fast heartbeat

• Quikhale SF 250 HFA based Inhaler is for maintenance therapy only and should not be used to treat a sudden asthma attack.
• Because this is a higher-strength inhaler, it should be used only when a clinician has decided that this strength is appropriate for your asthma control needs.
• Tell your doctor if you have heart disease, high blood pressure, fast heart rhythm, thyroid disease, diabetes, seizures, or low potassium.
• Use caution if you have a history of glaucoma, cataracts, or recurrent mouth infections.
• Rinse and spit after each dose to reduce the risk of oral fungal infection.
• Do not stop using it suddenly without medical advice, especially if you have been using it regularly.
• If you need your rescue inhaler more often than usual, contact your doctor promptly.

• Other LABA inhalers or medicines containing salmeterol
• Strong CYP3A4 inhibitors such as ketoconazole, ritonavir, or cobicistat
• Beta-blockers such as propranolol or timolol
• Diuretics that can lower potassium, such as furosemide or hydrochlorothiazide
• MAO inhibitors or tricyclic antidepressants

Store Quikhale SF 250 HFA based Inhaler at room temperature away from heat, open flame, and direct sunlight, and keep the cap on when not in use.